首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Prognostic factors in dogs with urinary bladder carcinoma
Authors:Rocha T A  Mauldin G N  Patnaik A K  Bergman P J
Institution:Donaldson-Atwood Cancer Clinic, The Animal Medical Center, New York, NY, USA. Rochatim@aol.com
Abstract:Medical records and biopsy specimens were retrospectively reviewed from 25 dogs diagnosed with unresectable urinary bladder carcinoma and treated with chemotherapy. Our intention was to identify clinical, histologic, and immunohistochemical indicators of prognosis. Immunohistochemical stains for P-glycoprotein, glutathione-S-transferase pi, and factor VIII-related antigen were applied to archived tissue. There were more spayed female dogs than castrated male dogs (76% versus 24%). Transitional cell carcinoma was the most common tumor (88%, n = 22), followed by undifferentiated carcinoma (8%, n = 2) and squamous cell carcinoma (4%, n = 1). Overall median survival was 251 days. Histologic diagnosis and immunohistochemical characteristics did not correlate with prognosis. Spayed females survived significantly longer than castrated males (358 days versus 145 days, P = .042). Dogs that received either doxorubicin or mitoxantrone in addition to a platinum-based chemotherapeutic (either cisplatin or carboplatin) lived significantly longer than those that received only a platinum compound (358 days versus 132 days, P = .042).
Keywords:Carboplatin  Chemotherapy  Cisplatin  Doxorubicin  Glutathione-S-transferase  Mitoxantrone  P-glycoprotein  Transitional cell carcinoma
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号